- Home
- EYEN vs CISS Comparison
EYEN vs CISS Comparison
Compare EYEN & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- CISS
- Stock Information
- Founded
- EYEN 2014
- CISS 2022
- Country
- EYEN United States
- CISS Greece
- Employees
- EYEN N/A
- CISS N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- CISS Marine Transportation
- Sector
- EYEN Health Care
- CISS Consumer Discretionary
- Exchange
- EYEN Nasdaq
- CISS Nasdaq
- Market Cap
- EYEN 4.0M
- CISS 4.7M
- IPO Year
- EYEN 2018
- CISS N/A
- Fundamental
- Price
- EYEN $1.68
- CISS $1.02
- Analyst Decision
- EYEN Hold
- CISS
- Analyst Count
- EYEN 4
- CISS 0
- Target Price
- EYEN $2.00
- CISS N/A
- AVG Volume (30 Days)
- EYEN 267.4K
- CISS 81.4K
- Earning Date
- EYEN 03-17-2025
- CISS 03-25-2025
- Dividend Yield
- EYEN N/A
- CISS N/A
- EPS Growth
- EYEN N/A
- CISS N/A
- EPS
- EYEN N/A
- CISS N/A
- Revenue
- EYEN $31,832.00
- CISS $46,661,732.00
- Revenue This Year
- EYEN $23,413.60
- CISS N/A
- Revenue Next Year
- EYEN $400.98
- CISS N/A
- P/E Ratio
- EYEN N/A
- CISS N/A
- Revenue Growth
- EYEN 2557.10
- CISS 491.48
- 52 Week Low
- EYEN $1.67
- CISS $0.90
- 52 Week High
- EYEN $205.60
- CISS $29.75
- Technical
- Relative Strength Index (RSI)
- EYEN 27.62
- CISS 32.70
- Support Level
- EYEN $1.67
- CISS $1.15
- Resistance Level
- EYEN $1.94
- CISS $1.21
- Average True Range (ATR)
- EYEN 0.26
- CISS 0.08
- MACD
- EYEN 0.22
- CISS 0.00
- Stochastic Oscillator
- EYEN 0.80
- CISS 32.43
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.